This report provides comprehensive information on the therapeutic development for Metastatic Hormone Refractory.
Albany, NY (PRWEB) April 13, 2014
Researchmoz presents this most up-to-date research on "Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014". The report focuses primarily on quantitative market metrics in order to characterize the growth and evolution of the Remote Patient Monitoring Market.
Global Markets Direct’s ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2014’ provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer’s therapeutic pipeline.
This report provides comprehensive information on the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer and special features on late-stage and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updating following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
For More Research Reports On Diseases & Conditions, Visit http://www.researchmoz.us/diseases-conditions-market-reports-67.html
The report provides a snapshot of the global therapeutic landscape of Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer
The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
The report reviews key players involved in the therapeutics development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer and enlists all their major and minor projects
The report summarizes all the dormant and discontinued pipeline projects
A review of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
A detailed assessment of monotherapy and combination therapy pipeline projects
Coverage of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer pipeline on the basis of target, MoA, route of administration and molecule type
Latest news and deals relating related to pipeline products
Browse Market Research Upcoming Reports:
Biosensors Market : Global Industry Analysis, Market Size, Share, Trends, Analysis, Growth And Forecast, 2013 - 2019 http://www.researchmoz.us/biosensors-market-resonant-mirror-electrochemical-surface-plasmon-resonance-light-addressable-potentiometric-global-industry-analysis-market-size-share-trends-analysis-growth-and-forecast-2013-2019-report.html
This market is expected to show the single digit growth in CAGR by 2019. Different companies are collaborating with universities to develop biosensors that are affordable, offer high precision and easy to use that acts as driving force for this market. In coming years, companies are investing and discovering non evasive decease monitors that are based on bio-sensing technologies. Biosensors are the devices used for the detection of analyte and combines physiological detector with biological components. There are certain types of biosensors that include resonant mirror, electrochemical, surface plasmon resonance and light addressable potentiometric. The biosensors market is expected to witness the growth owning to wide range of applications in cardiac monitoring, diabetes monitoring, agriculture, drug recovery, environmental practices and others.
Biosensors market is segmented into three aspects include- by applications, technologies and end use industries. The biosensor technology market include optical, electrochemical, thermistors and piezoelectric. The application segment covers wide range of biosensors applications such as medical testing, environmental, food toxicity, agriculture, industrial and others. The end user chapter include biosensors devices practiced by research laboratories, security and bio defense, home care diagnostic and others.
Hemophilia is a genetic disorder where the body fails to coagulate blood when blood vessel is ruptured. Between its variants, hemophilia A is more common than hemophilia B. A very rare form of hemophilia namely acquired hemophilia results from abnormalities in immune system of an individual. Acquired hemophilia is not a genetic disorder. Common symptoms of hemophilia are internal and external bleeding episodes. Currently, North America dominates the global hemophilia therapeutics market and is followed by Europe due to high rates of awareness about the available hemophilia treatments. Asia-Pacific is a promising market for hemophilia therapeutics and is expected to undergo rapid market growth due rapidly developing medical tourism industry, increase in purchasing power, rapidly improving healthcare infrastructure and increased awareness about overall healthcare and the available treatments. Some of the major companies contributing to global hemophilia therapeutics market are Pfizer Inc., Swedish Orphan Biovitrum AB, Baxter International Inc., Novo Nordisk A/S. and Bayer AG.
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
For All Latest Research Reports, Visit http://www.researchmoz.us/latest-report.html
Reasons to buy
Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop strategic initiatives by understanding the focus areas of leading companies
Identify and understand important and diverse types of therapeutics under development for Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Devise corrective measures for pipeline projects by understanding Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer pipeline depth and focus of Indication therapeutics
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
For All Category Wise Market Research Reports, Visit http://www.researchmoz.us/category.html
ResearchMoz is the one stop online destination to find and buy market research reports. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets.
Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.
90 Sate Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-997-4948
Email: sales (at) researchmoz (dot) us